Occudo Quantitative Strategies LP Kronos Bio, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $542 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.34 - $2.62 $17,466 - $34,151
13,035 Added 55.43%
36,552 $53,000
Q4 2022

Feb 14, 2023
SELL
$1.44 - $3.44 $12,761 - $30,485
-8,862 Reduced 27.37%
23,517 $38,000
Q3 2022

Nov 14, 2022
SELL
$3.35 - $5.55 $139,969 - $231,890
-41,782 Reduced 56.34%
32,379 $108,000
Q2 2022

Aug 15, 2022
BUY
$3.12 - $7.52 $231,382 - $557,690
74,161 New
74,161 $270,000

Others Institutions Holding KRON

# of Institutions
59
Shares Held
20.7M
Call Options Held
31.4K
Put Options Held
0
View Full List

About Kronos Bio, Inc.

KRON Quotes by TradingView
  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $55.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email